Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI

Aimée R Kreimer¹, Anil K Chaturvedi², Laia Alemany³, Devasena Anantharaman⁴, Freddie Bray⁵, Mary Carrington⁶, John Doorbar⁷, Gypsyamber D'Souza⁸, Carole Fakhry⁹, Robert L Ferris¹⁰, Maura Gillison¹¹, D Neil Hayes¹², Allan Hildesheim¹³, Shao Hui Huang¹⁴, Luiz P Kowalski¹⁵, Krystle A Lang Kuhs¹⁶, James Lewis Jr¹⁷, Douglas R Lowy¹⁸, Hisham Mehanna¹⁹, Andy Ness²⁰, Michael Pawlita²¹, Maisa Pinheiro²², John Schiller²³, Meredith S Shiels²⁴, Joseph Tota²⁵, Lisa Mirabello²⁶, Saman Warnakulasuriya²⁷, Tim Waterboer²⁸, William Westra²⁹, Stephen Chanock³⁰, Paul Brennan³¹

Affiliations

¹ Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: kreimera@mail.nih.gov.
² Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: chaturva@mail.nih.gov.
³ Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology and Public Health, Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: lalemany@iconcologia.net.
⁴ Rajiv Gandhi Centre for Biotechnology, Trivandrum, India. Electronic address: devasena@rgcb.res.in.
⁵ International Agency for Research on Cancer, Lyon, France. Electronic address: Brayf@iarc.fr.
⁶ Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, United States; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States. Electronic address: carringm@mail.nih.gov.
⁷ University of Cambridge, Cambridge, United Kingdom. Electronic address: jd121@cam.ac.uk.
⁸ Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States. Electronic address: Gdsouza2@jhu.edu.
⁹ Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD, United States. Electronic address: cfakhry@jhmi.edu.
¹⁰ UPMC Hillman Cancer Center, Pittsburgh, PA, United States. Electronic address: ferrrl@upmc.edu.
¹¹ The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: mgillison@mdanderson.org.
¹² The University of Tennessee Health Science Center, Memphis, TN, United States. Electronic address: Neil.Hayes@uthsc.edu.
¹³ Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: hildesha@exchange.nih.gov.
¹⁴ University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada. Electronic address: ShaoHui.Huang@rmp.uhn.ca.
¹⁵ A.C. Camargo Cancer Center, São Paulo, Brazil. Electronic address: lp_kowalski@uol.com.br.
¹⁶ Vanderbilt University Medical Center, Nashville, TN, United States. Electronic address: krystle.kuhs@vumc.org.
¹⁷ Vanderbilt University Medical Center, Nashville, TN, United States. Electronic address: james.lewis@vanderbilt.edu.
¹⁸ Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States; Office of the Director, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: lowyd@mail.nih.gov.
¹⁹ Institute for Head and Neck Studies and Education, University of Birmingham, Birmingham, United Kingdom. Electronic address: h.mehanna@bham.ac.uk.
²⁰ NIHR Bristol Biomedical Research Centre, University of Bristol NHS Foundation Trust and University of Bristol, Bristol, United Kingdom. Electronic address: Andy.Ness@bristol.ac.uk.
²¹ German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: m.pawlita@dkfz-heidelberg.de.
²² Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: maisa.pinheiro@nih.gov.
²³ Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: schillej@dc37a.nci.nih.gov.
²⁴ Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: shielsms@mail.nih.gov.
²⁵ Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: joseph.tota@nih.gov.
²⁶ Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: mirabellol@mail.nih.gov.
²⁷ King's College London, London, United Kingdom; WHO Collaborating Centre for Oral Cancer, United Kingdom. Electronic address: saman.warne@kcl.ac.uk.
²⁸ German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: T.Waterboer@dkfz-heidelberg.de.
²⁹ Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: william.westra@mountsinai.org.
³⁰ Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: hanocks@mail.nih.gov.
³¹ International Agency for Research on Cancer, Lyon, France. Electronic address: gep@iarc.fr.

PMID: 32502860
PMCID: PMC7909748
DOI: 10.1016/j.oraloncology.2020.104736

Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI

Aimée R Kreimer et al. Oral Oncol. 2020 Sep.

. 2020 Sep:108:104736.

doi: 10.1016/j.oraloncology.2020.104736. Epub 2020 Jun 2.

Authors

Affiliations

¹ Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: kreimera@mail.nih.gov.
² Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: chaturva@mail.nih.gov.
³ Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology and Public Health, Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: lalemany@iconcologia.net.
⁴ Rajiv Gandhi Centre for Biotechnology, Trivandrum, India. Electronic address: devasena@rgcb.res.in.
⁵ International Agency for Research on Cancer, Lyon, France. Electronic address: Brayf@iarc.fr.
⁶ Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, United States; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States. Electronic address: carringm@mail.nih.gov.
⁷ University of Cambridge, Cambridge, United Kingdom. Electronic address: jd121@cam.ac.uk.
⁸ Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States. Electronic address: Gdsouza2@jhu.edu.
⁹ Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD, United States. Electronic address: cfakhry@jhmi.edu.
¹⁰ UPMC Hillman Cancer Center, Pittsburgh, PA, United States. Electronic address: ferrrl@upmc.edu.
¹¹ The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: mgillison@mdanderson.org.
¹² The University of Tennessee Health Science Center, Memphis, TN, United States. Electronic address: Neil.Hayes@uthsc.edu.
¹³ Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: hildesha@exchange.nih.gov.
¹⁴ University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada. Electronic address: ShaoHui.Huang@rmp.uhn.ca.
¹⁵ A.C. Camargo Cancer Center, São Paulo, Brazil. Electronic address: lp_kowalski@uol.com.br.
¹⁶ Vanderbilt University Medical Center, Nashville, TN, United States. Electronic address: krystle.kuhs@vumc.org.
¹⁷ Vanderbilt University Medical Center, Nashville, TN, United States. Electronic address: james.lewis@vanderbilt.edu.
¹⁸ Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States; Office of the Director, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: lowyd@mail.nih.gov.
¹⁹ Institute for Head and Neck Studies and Education, University of Birmingham, Birmingham, United Kingdom. Electronic address: h.mehanna@bham.ac.uk.
²⁰ NIHR Bristol Biomedical Research Centre, University of Bristol NHS Foundation Trust and University of Bristol, Bristol, United Kingdom. Electronic address: Andy.Ness@bristol.ac.uk.
²¹ German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: m.pawlita@dkfz-heidelberg.de.
²² Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: maisa.pinheiro@nih.gov.
²³ Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: schillej@dc37a.nci.nih.gov.
²⁴ Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: shielsms@mail.nih.gov.
²⁵ Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: joseph.tota@nih.gov.
²⁶ Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: mirabellol@mail.nih.gov.
²⁷ King's College London, London, United Kingdom; WHO Collaborating Centre for Oral Cancer, United Kingdom. Electronic address: saman.warne@kcl.ac.uk.
²⁸ German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: T.Waterboer@dkfz-heidelberg.de.
²⁹ Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: william.westra@mountsinai.org.
³⁰ Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, United States. Electronic address: hanocks@mail.nih.gov.
³¹ International Agency for Research on Cancer, Lyon, France. Electronic address: gep@iarc.fr.

PMID: 32502860
PMCID: PMC7909748
DOI: 10.1016/j.oraloncology.2020.104736

Abstract

Cancer of the oropharynx has attracted considerable attention in recent years given: (1) an increasing incidence in selected populations over the past three decades; (2) the discovery of human papillomavirus (HPV) infection as the driver of the increase, as opposed to the traditional risk factors such as tobacco (smoking and chewing) and alcohol; and (3) the promise of new prevention and treatment strategies. As a result of such developments, the International Agency for Research on Cancer (IARC) and the US National Cancer Institute (NCI), convened the fourth Cancer Seminar meeting in November 2018 to focus on this topic. This report summarizes the proceedings: a review of recent science on the descriptive epidemiology, etiology, biology, genetics, early detection, pathology and treatment of HPV-positive oropharyngeal cancer, and the formulation of key research questions to be addressed.

Keywords: Etiology; Genetics; HPV; Oropharynx cancer; Prevention; Screening; Therapy.

Published by Elsevier Ltd.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests:

The authors have declared no conflicts of interest.

References

1. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31:4550–9. 10.1200/JCO.2013.50.3870 - DOI - PMC - PubMed
1. Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F, et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin. 2017;67:51–64. 10.3322/caac.21384 - DOI - PubMed
1. Hwang TZ, Hsiao JR, Tsai CR, Chang JS. Incidence trends of human papillomavirus-related head and neck cancer in Taiwan, 1995–2009. Int J Cancer. 2015;137:395–408. 10.1002/ijc.29330 - DOI - PubMed
1. Mork J, Moller B, Dahl T, Bray F. Time trends in pharyngeal cancer incidence in Norway 1981–2005: a subsite analysis based on a reabstraction and recoding of registered cases. Cancer Causes Control. 2010;21:1397–405. 10.1007/s10552-010-9567-9 - DOI - PubMed
1. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294–301. 10.1200/JCO.2011.36.4596 - DOI - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI

Affiliations

Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI

Authors

Affiliations

Abstract

Conflict of interest statement

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Research Materials

Miscellaneous